Table 3.
Measures of Correspondence For Comparisons of Manual Chart Review vs. Automated Extraction of EHR Data and Medicaid Claims Data
| Measure (N=150 patients per measure) |
Agreement (%) |
Kappa (95% CI) | Sensitivity (95% CI) |
Specificity (95% CI) |
PPV (95% CI) |
NPV (95% CI) |
|---|---|---|---|---|---|---|
| BMI assessment | ||||||
| MCR vs. EHR, received | 100 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
| MCR vs. claims, received | 12.7 | 0.002 (−0.002, 0.006) | 0.008 (0.0002, 0.04) | 1.0 | 1.0 | 0.12 (0.07, 0.18) |
| Blood pressure assessment | ||||||
| MCR vs. EHR, received | 100 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
| MCR vs. claims, received | 0.7 | -- | -- | 1.0 | -- | 0.007 (0.0002, 0.04) |
| Smoking status assessment | ||||||
| MCR vs. EHR, received | 94.0 | 0.66 (0.45, 0.86) | 0.97 (0.93, 0.99) | 0.67 (0.38, 0.88) | 0.96 (0.92, 0.99) | 0.71 (0.42, 0.92) |
| MCR vs. claims, received | 10.0 | -- | -- | 1.0 | -- | 0.10 (0.06, 0.16) |
| Hyperlipidemia screeninga | ||||||
| MCR vs. EHR, ordered | 94.0 | 0.87 (0.78, 0.95) | 0.88 (0.77, 0.96) | 0.97 (0.91, 0.99) | 0.94 (0.83, 0.99) | 0.94 (0.88, 0.98) |
| MCR vs. EHR, received | 99.3 | 0.98 (0.96, 1.0) | 1.0 | 0.99 (0.95, 1.0) | 0.98 (0.89, 1.0) | 1.0 |
| MCR vs. claims, received | 94.0 | 0.87 (0.78, 0.95) | 0.98 (0.89, 1.0) | 0.92 (0.85, 0.97) | 0.85 (0.73, 0.94) | 0.99 (0.94, 1.0) |
| Diabetes screeningb | ||||||
| MCR vs. EHR, ordered | 92.7 | 0.85 (0.76, 0.93) | 0.93 (0.84, 0.98) | 0.92 (0.85, 0.97) | 0.89 (0.78, 0.95) | 0.95 (0.89, 0.99) |
| MCR vs. EHR, received | 98.0 | 0.96 (0.91, 1.0) | 0.98 (0.90, 1.0) | 0.98 (0.93, 1.0) | 0.96 (0.88, 1.0) | 0.99 (0.94, 1.0) |
| MCR vs. claims, received | 94.0 | 0.87 (0.79, 0.95) | 0.95 (0.85, 0.99) | 0.94 (0.87, 0.98) | 0.89 (0.79, 0.96) | 0.97 (0.91, 0.99) |
| Influenza vaccinationc | ||||||
| MCR vs. EHR, received | 98.0 | 0.96 (0.91, 1.0) | 0.97 (0.88, 1.0) | 0.99 (0.94, 1.0) | 0.98 (0.91, 1.0) | 0.98 (0.92, 1.0) |
| MCR vs. claims, received | 88.0 | 0.74 (0.63, 0.85) | 0.75 (0.62, 0.85) | 0.97 (0.91, 0.99) | 0.94 (0.83, 0.99) | 0.85 (0.77, 0.92) |
| Chlamydia screeningd | ||||||
| MCR vs. EHR, ordered | 98.7 | 0.97 (0.93, 1.0) | 1.0 | 0.98 (0.92, 1.0) | 0.97 (0.89, 1.0) | 1.0 |
| MCR vs. EHR, received | 98.0 | 0.96 (0.91, 1.0) | 0.98 (0.91, 1.0) | 0.98 (0.92, 1.0) | 0.97 (0.89, 1.0) | 0.99 (0.94, 1.0) |
| MCR vs. claims, received | 79.3 | 0.59 (0.47, 0.72) | 0.92 (0.82, 0.97) | 0.71 (0.61, 0.80) | 0.68 (0.57, 0.78) | 0.93 (0.84, 0.98) |
| Cervical cancer screeninge | ||||||
| MCR vs. EHR, ordered | 93.3 | 0.83 (0.73, 0.93) | 0.81 (0.67, 0.92) | 0.98 (0.93, 1.0) | 0.95 (0.82, 0.99) | 0.93 (0.87, 0.97) |
| MCR vs. EHR, received | 97.3 | 0.93 (0.87, 1.0) | 0.93 (0.80, 0.98) | 0.99 (0.95, 1.0) | 0.97 (0.86, 1.0) | 0.97 (0.92, 1.0) |
| MCR vs. claims, received | 86.7 | 0.67 (0.54, 0.80) | 0.78 (0.62, 0.89) | 0.90 (0.83, 0.95) | 0.74 (0.59, 0.86) | 0.92 (0.85, 0.96) |
| Breast cancer screeningf | ||||||
| MCR vs. EHR, ordered | 98.0 | 0.95 (0.89, 1.0) | 0.93 (0.81, 0.99) | 1.0 | 1.0 | 0.97 (0.92, 0.99) |
| MCR vs. EHR, received | 80.0 | 0.42 (0.27, 0.57) | 0.36 (0.22, 0.51) | 0.99 (0.95, 1.0) | 0.94 (0.71, 1.0) | 0.78 (0.70, 0.85) |
| MCR vs. claims, received | 91.3 | 0.80 (0.70, 0.90) | 0.91 (0.79, 0.98) | 0.91 (0.84, 0.96) | 0.82 (0.69, 0.91) | 0.96 (0.90, 0.99) |
| Colorectal cancer screeningg | ||||||
| MCR vs. EHR, ordered | 96.7 | 0.91 (0.84, 0.99) | 0.88 (0.73, 0.96) | 1.0 | 1.0 | 0.96 (0.90, 0.99) |
| MCR vs. EHR, received | 90.7 | 0.62 (0.44, 0.79) | 0.50 (0.31, 0.69) | 1.0 | 1.0 | 0.90 (0.83, 0.94) |
| MCR vs. claims, received | 93.3 | 0.79 (0.66, 0.91) | 0.85 (0.67, 0.96) | 0.95 (0.90, 0.98) | 0.80 (0.61, 0.92) | 0.97 (0.92, 0.99) |
Notes: 95% CIs were obtained using exact binomial CIs for proportions
-- Statistic cannot be computed due to zero cell count in claims data Eligibility was based recommended age, sex, and medical history, not whether patient was due for a service
Males and females ages 20-64; cholesterol screening includes LDL, HDL, total cholesterol, and triglycerides
Males and females ages 45-64
Males and females ages 50-64
Sexually active females ages 19-24
Females ages 19-64 with no history of hysterectomy
Females ages 40-64 with no history of bilateral mastectomy
Males and females ages 50-64 with no history of colorectal cancer or total colectomy; colorectal cancer screening includes fecal occult blood test, flexible sigmoidoscopy, and colonoscopy
EHR, electronic health record; MCR, manual chart review; PPV, positive predictive value; NPV, negative predictive value